Latest Insider Transactions at Dicerna Pharmaceuticals Inc (DRNA)
This section provides a real-time view of insider transactions for Dicerna Pharmaceuticals Inc (DRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Dicerna Pharmaceuticals Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Dicerna Pharmaceuticals Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,000
-78.8%
|
$38,000
$38.0 P/Share
|
|
Jun 25
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+44.07%
|
$22,000
$22.58 P/Share
|
|
Jun 22
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
18,435
-83.62%
|
$663,660
$36.9 P/Share
|
|
Jun 22
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,435
+24.39%
|
$350,265
$19.85 P/Share
|
|
Jun 17
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
8,664
-96.99%
|
$303,240
$35.79 P/Share
|
|
Jun 17
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,664
+39.76%
|
$155,952
$18.49 P/Share
|
|
Jun 16
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
31,564
-62.97%
|
$1,104,740
$35.89 P/Share
|
|
Jun 16
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,564
+26.39%
|
$631,280
$20.71 P/Share
|
|
Jun 15
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
112
-29.4%
|
$3,920
$35.74 P/Share
|
|
Jun 15
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
381
+50.0%
|
-
|
|
Jun 15
2021
|
Douglas W. Pagan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,004
-25.81%
|
$70,140
$35.74 P/Share
|
|
Jun 15
2021
|
Douglas W. Pagan Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,825
+46.78%
|
-
|
|
Jun 14
2021
|
Robert D. Ciappenelli Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
20,000
-84.13%
|
$760,000
$38.0 P/Share
|
|
Jun 14
2021
|
Robert D. Ciappenelli Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+45.69%
|
$300,000
$15.61 P/Share
|
|
Jun 11
2021
|
Robert D. Ciappenelli Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
10,000
-72.61%
|
$350,000
$35.0 P/Share
|
|
Jun 11
2021
|
Robert D. Ciappenelli Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+42.06%
|
$150,000
$15.61 P/Share
|
|
Jun 11
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
10,000
-31.73%
|
$340,000
$34.0 P/Share
|
|
Jun 11
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.09%
|
$90,000
$9.09 P/Share
|
|
Jun 07
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
10,000
-31.73%
|
$330,000
$33.0 P/Share
|
|
Jun 07
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.09%
|
$90,000
$9.09 P/Share
|
|
Jun 03
2021
|
Adam Koppel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|
|
Jun 03
2021
|
Stephen K Doberstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|
|
Jun 03
2021
|
Patrick M. Gray Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|
|
Jun 03
2021
|
J Kevin Buchi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,666
+50.0%
|
-
|
|
Jun 03
2021
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|
|
Jun 03
2021
|
Martin I Freed Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|
|
Jun 03
2021
|
Marc D Kozin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|
|
Jun 03
2021
|
Cynthia Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|
|
Jun 03
2021
|
Stephen J Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+10.29%
|
-
|
|
Jun 01
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
8,312
-14.14%
|
$257,672
$31.45 P/Share
|
|
Jun 01
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+21.79%
|
$24,936
$3.42 P/Share
|
|
Jun 01
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,431
-96.56%
|
$137,361
$31.42 P/Share
|
|
Jun 01
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,431
+50.0%
|
$53,172
$12.93 P/Share
|
|
May 03
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
8,312
-9.7%
|
$249,360
$30.94 P/Share
|
|
May 03
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+21.79%
|
$24,936
$3.42 P/Share
|
|
May 03
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,431
-94.64%
|
$132,930
$30.71 P/Share
|
|
May 03
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,431
+50.0%
|
$53,172
$12.93 P/Share
|
|
Apr 30
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
10,000
-31.73%
|
$320,000
$32.0 P/Share
|
|
Apr 30
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.09%
|
$90,000
$9.09 P/Share
|
|
Apr 29
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
10,000
-31.73%
|
$310,000
$31.0 P/Share
|
|
Apr 29
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.09%
|
$90,000
$9.09 P/Share
|
|
Apr 16
2021
|
James B Weissman Chief Operating Officer & EVP |
SELL
Open market or private sale
|
Direct |
4,904
-23.46%
|
$142,216
$29.99 P/Share
|
|
Apr 01
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,431
-100.0%
|
$110,775
$25.86 P/Share
|
|
Apr 01
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,431
+50.0%
|
$53,172
$12.93 P/Share
|
|
Apr 01
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
8,312
-14.05%
|
$216,112
$26.18 P/Share
|
|
Apr 01
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+21.79%
|
$24,936
$3.42 P/Share
|
|
Mar 01
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,431
-95.98%
|
$128,499
$29.2 P/Share
|
|
Mar 01
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,431
+50.0%
|
$53,172
$12.93 P/Share
|
|
Mar 01
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
8,312
-14.38%
|
$241,048
$29.2 P/Share
|
|
Mar 01
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+21.79%
|
$74,808
$9.09 P/Share
|